Current Liabilities Endring Dato
AbbVie USD 34.77B 2.53B 2023-09
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Amgen USD 18.39B 1.44B 2023-12
Astellas Pharma JPY 1.16T 170.76B 2023-09
Bayer EUR 33.08B 894M 2023-09
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Celldex Therapeutics USD 31.12M 3.29M 2023-12
Daiichi Sankyo JPY 532.25B 19.14B 2023-09
Eisai JPY 307.31B 11.44B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Exelixis USD 376.82M 37.2M 2023-09
Genmab DKK 2.9B 909M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Incyte USD 1.24B 115.7M 2023-12
Insmed USD 225.63M 28.9M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Takeda JPY 2.37T 134.12B 2023-09
Teva Pharmaceutical Industries USD 11.39B 449M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09
Xencor USD 84.71M 31.67M 2023-12



Seattle Genetics Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.